As of now, the start of 2025, there are several Chinese industrial parks in Mexico, with notable examples including the ...

The Anglo-Swedish pharmaceutical giant AstraZeneca faces mounting pressure from shareholders regarding ongoing investigations in China, one of its key markets. The concerns emerged after the detention ...

Despite staying relatively quiet in 2025, it'd be unfair to say that New York Knicks president Leon Rose wilts at the NBA ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

AstraZeneca (NASDAQ:AZN) shares gained in European trading on Thursday after the Anglo-Swedish drugmaker reported better-than-expected Q4 2024 results and addressed investor concerns over an ...

AstraZeneca appointed a new president for its China operations following the arrest of former executive Leon Wang along with ...

Shares in drugs giant AstraZeneca (AZN) looked perkier today as it reported a rise in sales and eased investor fears over the ...

The company said, “In relation to the illegal drug importation allegations, in January 2025, AstraZeneca (AZN) received a Notice of Transfer to ...

AstraZeneca has been approached a couple of times by Chinese authorities about their investigation into the drugmaker's ...

AstraZeneca faces potential fines in China over import taxes - It came as the Cambridge-based firm revealed strong sales of ...

This summary covers recent health news, including stable pig prices in Germany, investor focus on AstraZeneca's China probe, ...